Riskpilot← Back to searchSign inGet full accessAnders Norberg Förvaltnings AB
ABActiveOrg 5569829764Prins Georgs Gata 2 DWholesale of pharmaceutical and medical goods · NACE 4646Est. 20141 employees
Revenue 2025
SEK 120K
0% vs 2024
EBITDA margin
-88.2%
+82% vs 2024
Equity ratio
98.9%
Financial strength
Net profit 2025
SEK 441K
-62% vs 2024
| Revenue | SEK 120K | +0% |
| EBITDA | SEK -106K | +82% |
| Net profit | SEK 441K | -62% |
| Total assets | SEK 15,5M | -3% |
| Equity | SEK 15,4M | -3% |
| Employees | 1 | — |
Legal name
Anders Norberg Förvaltnings AB
Org number
5569829764
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 september 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall äga och förvalta aktier samt direkt och/eller in- direkt äga och förvalta fastigheter samt genom dotterbolaget bedriva partihandel med läkemedel. Bolaget skall även bedriva konsultverksamhet inom de olika verksamhetsområdena och därmed förenlig verksamhet.
Address
Prins Georgs Gata 2 D
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 80 | 70 | 120 | 120 | 120 |
| Staff expenses | — | — | — | −441 | −115 |
| EBITDA | 16 | −511 | −647 | −594 | −106 |
| Depreciation & amort. | −0 | −0 | −3 | −13 | −13 |
| EBIT | 16 | −511 | −650 | −606 | −119 |
| Net financials | 2 113 | 68 | 3 291 | 1 276 | 717 |
| Profit before tax | 1 628 | −203 | 2 659 | 1 181 | 598 |
| Tax | −337 | −0 | −0 | −26 | −157 |
| Net profit | 1 291 | −203 | 2 659 | 1 155 | 441 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 14 580 | 13 855 | 16 423 | 15 979 | 15 530 |
| Equity | 13 834 | 13 181 | 15 840 | 15 895 | 15 355 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 246 | 222 | 148 | 84 | 175 |
| Total debt | 246 | 222 | 148 | 84 | 175 |
EBITDA margin
-88.2%
This company
15.8%
Market median
-658% vs market
20212025
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20212025
Net profit margin
367.3%
This company
8.1%
Market median
+4435% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LT Chief Auditor | Chief Auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Deputy Board Member | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anders Norberg Förvaltnings AB 
Pro Health Pharma Sweden ABBoard members of Anders Norberg Förvaltnings AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Tobias Daniel Carlsson | Chief Auditor | 0 companies |
| Björn Alexander Norberg | Board of Directors | 0 companies |
| Karl Oscar Anders Norberg | Board of Directors | 0 companies |
| Bengt Anders Norberg | Chairman | 0 companies |
| Michael Magnus Lettius | Deputy Board Member | 0 companies |